[1] Disertori M, Masè M, Ravelli F. Myocardial fibrosis predicts ventricular tachyarrhythmias[J]. Trends Cardiovasc Med, 2017, 27(5):363-372.
[2] Katritsis DG, Siontis GC, Camm AJ. Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias[J]. Prog Cardiovasc Dis, 2013, 56(2):133-142.
[3] Campbell MJ, Zhou X, Han C, et al. Electrocardiography screening for hypertrophic cardiomyopathy[J]. Pacing Clin Electrophysiol, 2016, 39(9):944-950.
[4] Schmehil C, Malhotra D, Patel DR. Cardiac screening to prevent sudden death in young athletes[J]. Transl Pediatr, 2017, 6(3):199-206.
[5] Anzouan-Kacou JB, Ncho-Mottoh MP, Konin C, et al. Prevalence of cardiac dyssynchrony and correlation with atrio-ventricular block and QRS width in dilated cardiomyopathy: an echocardiographic study[J]. Cardiovasc J Afr, 2012, 23(7):85-388.
[6] Rijnierse MT, De Haan S, Harms HJ, et al. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy[J]. Circ Cardiovasc Imaging, 2014, 7(1):20-30.
[7] Chang KW, Fox S, Mojaver S, et al. Using biomarkers to guide heart failure management[J]. Expert Rev Cardiovasc Ther, 2017, 15(10):729-741.
[8] Jayachandra A, Aggarwal V. To evaluate the change in brain natriuretic peptide levels in outpatients with ischemic cardiomyopathy and its association with functional capacity: a pilot study[J]. J Clin Diagn Res, 2017, 11(6):OC26-OC28.
[9] Liao JN, Chao TF, Kuo JY, et al. Age, sex, and blood pressure-related influences on reference values of left atrial deformation and mechanics from a large-scale Asian population[J]. Circ Cardiovasc Imaging, 2017, 10(10):e006077.